Cite
A doxycycline-inducible CYP3A4-Caco-2 cell line as a model for evaluating safety of aflatoxin B1 in the human intestine.
MLA
Bai, Lin, et al. “A Doxycycline-Inducible CYP3A4-Caco-2 Cell Line as a Model for Evaluating Safety of Aflatoxin B1 in the Human Intestine.” Toxicology Letters, vol. 370, Nov. 2022, pp. 1–6. EBSCOhost, https://doi.org/10.1016/j.toxlet.2022.09.005.
APA
Bai, L., Tachibana, K., Murata, M., Inoue, T., Mizuguchi, H., Maeda, S., Ikemura, K., Okuda, M., Kusakabe, T., & Kondoh, M. (2022). A doxycycline-inducible CYP3A4-Caco-2 cell line as a model for evaluating safety of aflatoxin B1 in the human intestine. Toxicology Letters, 370, 1–6. https://doi.org/10.1016/j.toxlet.2022.09.005
Chicago
Bai, Lin, Keisuke Tachibana, Michika Murata, Tetsunori Inoue, Hiroyuki Mizuguchi, Shinichiro Maeda, Kenji Ikemura, Masahiro Okuda, Tetsuya Kusakabe, and Masuo Kondoh. 2022. “A Doxycycline-Inducible CYP3A4-Caco-2 Cell Line as a Model for Evaluating Safety of Aflatoxin B1 in the Human Intestine.” Toxicology Letters 370 (November): 1–6. doi:10.1016/j.toxlet.2022.09.005.